Further, our identification of increased IL8, IL6, HAS2, and ICAM1, as well as decreased ERBB2 in MpBC samples matches findings from a microarray comparison of gene expression between metaplastic breast cancers and ductal carcinomas of the breast [22]. This evidence concerns the gene HAS2 and breast ductal adenocarcinoma.